A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine
Clinical trial NCT06337643 · UNKNOWN
Trial details
- NCT number
- NCT06337643
- Sponsor
- Matrivax Research and Development Corporation
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2024-04-16
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.